Join
Search

Celia Wexler

Author image

About the author: Celia Wexler is a senior Washington representative for the Scientific Integrity Initiative at UCS. A former award-winning journalist, Wexler is the author of Out of the News: Former Journalists Discuss a Profession in Crisis, published in 2012 by McFarland. At UCS, Wexler’s issue portfolio includes food and drug safety, protections for scientist whistleblowers, and government transparency and accountability. See Celia's full bio.

Bad Policies Should Not Get a Free “Ride” on Spending Bills

I try hard not to be cynical about Congress. I believe that in the House and Senate, many men and women of good will and their staffs work hard to advance policies that they believe will benefit the people they represent. Our elected representatives may disagree about what the best solutions are. But they are motivated by the desire to do good, not ill.

That sentiment is being tested as the House and Senate vote on a series of spending bills to pay for government agencies and other expenses in the coming fiscal year. Read More

Bookmark and Share

4 Ways “Fast Track” Is a Bad Deal for Science

Soon, members of the House of Representatives will cast a vote that could affect every American family for years to come. The vote is on Trade Promotion Authority, or fast-track, legislation that would give not only the current President but also a future president the power to negotiate complicated trade deals and then submit them to Congress for an up-or-down vote. The Senate approved fast-track in late May, after a spirited debate that raised many concerns about the wisdom of this approach. Read More

Bookmark and Share

Why “Fast Track” Can Sidetrack Both Science and Democracy

Congress soon will be voting on whether to approve Trade Promotion Authority, or fast-track, a process that expedites approval of trade deals but at the expense of democratic discourse and public and congressional scrutiny and oversight.

Read More

Bookmark and Share

Beware of This Zombie Bill: The Regulatory Accountability Act Returns from the Dead

The House leadership has promised a new day for Congress. Less partisanship, more governing. But it’s hard to believe them when first out of the gate the House chooses to recycle one of its most divisive bills, and one which would greatly harm science-informed policymaking at federal agencies.

Read More

Bookmark and Share

FDA Head Speaks Up for Science

When President Obama asked Dr. Margaret Hamburg to head the Food and Drug Administration in 2009, he chose a seasoned scientist with a demonstrated passion for public health.  Read More

Bookmark and Share

Public Health Service Scientists Deserve Robust Whistleblower Protections

If you ever wanted Public Health Service scientists to have strong whistleblower rights, it would be now. In the face of an Ebola epidemic in West Africa, 65 PHS medical staffers have agreed to assist in combatting this frightening disease. Read More

Bookmark and Share

“Hide No Harm” Bill Will Tip the Balance in Favor of Science and Safety over Corporate Profits

On July 16, Senators Richard Blumenthal (CT), Tom Harkin (IA) and Robert Casey (PA) introduced S. 2615, the “Hide No Harm Act.” Their legislation would impose criminal penalties—fines and even imprisonment—on corporate executives if they knowingly failed to warn the public about life-threatening dangers in their products. Read More

Bookmark and Share

Openness Effort Trumps Partisan Gridlock in Congress

You can probably count on the fingers of one hand the issues on which there is bipartisan agreement in Congress. Fortunately, strengthening Freedom of Information (FOIA)  is one of them. Read More

Bookmark and Share

Not Easy to Declare Independence from Sugar

Our Center for Science and Democracy has been busy studying sugar, its health impacts, and the ways that the sugar industry tries to undermine the science that shows that sugar is not a sweet deal for American families. Read More

Bookmark and Share

Sometimes the Good Guys Win: Unmasking “Company Doe”

Last week a federal district appeals court issued a decision that is a victory for scientific integrity, transparency,  and consumer protection. Read More

Bookmark and Share